25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

PharmaSGP Holding SE
Buy, Hold or Sell?

Let's analyze Pharmasgp together

I guess you are interested in PharmaSGP Holding SE. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of PharmaSGP Holding SE. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about PharmaSGP Holding SE

I send you an email if I find something interesting about PharmaSGP Holding SE.

1. Quick Overview

1.1. Quick analysis of Pharmasgp (30 sec.)










1.2. What can you expect buying and holding a share of Pharmasgp? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
34.8%

What is your share worth?

Current worth
€3.08
Expected worth in 1 year
€3.11
How sure are you?
82.6%

+ What do you gain per year?

Total Gains per Share
€0.03
Return On Investment
0.1%

For what price can you sell your share?

Current Price per Share
€26.00
Expected price per share
€23.40 - €27.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Pharmasgp (5 min.)




Live pricePrice per Share (EOD)
€26.00
Intrinsic Value Per Share
€294.80 - €354.15
Total Value Per Share
€297.88 - €357.23

2.2. Growth of Pharmasgp (5 min.)




Is Pharmasgp growing?

Current yearPrevious yearGrowGrow %
How rich?$38.7m$34.8m$5.5m13.7%

How much money is Pharmasgp making?

Current yearPrevious yearGrowGrow %
Making money$4.9m$3.9m$998.5k20.3%
Net Profit Margin16.5%15.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Pharmasgp (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Pharmasgp?

Welcome investor! Pharmasgp's management wants to use your money to grow the business. In return you get a share of Pharmasgp.

First you should know what it really means to hold a share of Pharmasgp. And how you can make/lose money.

Speculation

The Price per Share of Pharmasgp is €26.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pharmasgp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pharmasgp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €3.08. Based on the TTM, the Book Value Change Per Share is €0.01 per quarter. Based on the YOY, the Book Value Change Per Share is €0.19 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pharmasgp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.471.8%0.411.6%0.351.4%0.311.2%0.311.2%
Usd Book Value Change Per Share0.381.5%0.010.0%0.200.8%0.160.6%0.140.5%
Usd Dividend Per Share0.000.0%0.000.0%0.130.5%0.953.6%0.843.2%
Usd Total Gains Per Share0.381.5%0.010.0%0.331.3%1.114.3%0.983.8%
Usd Price Per Share21.61-23.13-28.11-23.29-20.25-
Price to Earnings Ratio11.49-14.25-20.29-54.43-47.33-
Price-to-Total Gains Ratio56.91-43.05-11.44-222.56-222.56-
Price to Book Ratio6.69-6.97-9.73-13.65-11.87-
Price-to-Total Gains Ratio56.91-43.05-11.44-222.56-222.56-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share27.2714
Number of shares36
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.95
Usd Book Value Change Per Share0.010.16
Usd Total Gains Per Share0.011.11
Gains per Quarter (36 shares)0.2939.87
Gains per Year (36 shares)1.17159.49
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101-913623149
202-827247308
304-740970467
405-654593626
506-5681116785
607-4817140944
708-39541631103
809-210901861262
9011-112262091421
10012013622331580

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%23.00.00.0100.0%23.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%16.04.00.080.0%16.04.03.069.6%16.04.03.069.6%
Dividend per Share0.00.04.00.0%4.00.08.033.3%7.00.013.035.0%8.00.015.034.8%8.00.015.034.8%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%18.02.00.090.0%19.02.02.082.6%19.02.02.082.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of PharmaSGP Holding SE compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3620.008+4581%0.188+92%0.154+135%0.134+170%
Book Value Per Share--3.0813.210-4%2.771+11%2.727+13%2.372+30%
Current Ratio--2.2652.285-1%2.293-1%2.737-17%2.380-5%
Debt To Asset Ratio--0.7150.713+0%0.748-4%0.637+12%0.554+29%
Debt To Equity Ratio--2.5052.519-1%2.979-16%2.5080%2.181+15%
Dividend Per Share----0%0.122-100%0.902-100%0.804-100%
Enterprise Value--192205360.000210205189.700-9%259997048.700-26%247814386.272-22%247814386.272-22%
Eps--0.4480.392+14%0.337+33%0.294+52%0.295+52%
Ev To Ebitda Ratio--4.5195.536-18%7.958-43%23.094-80%23.094-80%
Ev To Sales Ratio--1.5911.858-14%2.681-41%3.176-50%3.176-50%
Free Cash Flow Per Share--1.2040.552+118%0.529+127%0.063+1802%0.100+1106%
Free Cash Flow To Equity Per Share---0.2190.024-998%0.171-228%-0.190-14%-0.141-36%
Gross Profit Margin---1.387-1.693+22%-4.066+193%-16.958+1122%-14.986+980%
Intrinsic Value_10Y_max--354.149--------
Intrinsic Value_10Y_min--294.795--------
Intrinsic Value_1Y_max--7.199--------
Intrinsic Value_1Y_min--7.055--------
Intrinsic Value_3Y_max--43.190--------
Intrinsic Value_3Y_min--40.797--------
Intrinsic Value_5Y_max--105.173--------
Intrinsic Value_5Y_min--95.763--------
Market Cap311745200.000+21%247006360.000264386189.700-7%321434798.700-23%266524697.645-7%231760606.648+7%
Net Profit Margin--0.1780.165+7%0.153+16%0.166+7%0.176+1%
Operating Margin--0.2740.255+7%0.246+11%0.239+15%0.249+10%
Operating Ratio--1.0000.827+21%0.771+30%0.763+31%0.753+33%
Pb Ratio8.438+21%6.6856.970-4%9.735-31%13.649-51%11.869-44%
Pe Ratio14.506+21%11.49314.245-19%20.287-43%54.432-79%47.333-76%
Price Per Share26.000+21%20.60022.050-7%26.800-23%22.207-7%19.310+7%
Price To Free Cash Flow Ratio5.400+21%4.278-9.197+315%13.611-69%13.400-68%11.652-63%
Price To Total Gains Ratio71.834+21%56.91543.051+32%11.436+398%222.562-74%222.562-74%
Quick Ratio--1.8041.840-2%1.888-4%2.402-25%2.089-14%
Return On Assets--0.0410.035+18%0.028+46%0.046-10%0.040+3%
Return On Equity--0.1450.123+18%0.112+29%0.139+4%0.127+15%
Total Gains Per Share--0.3620.008+4581%0.311+16%1.056-66%0.938-61%
Usd Book Value--38754757.20040375832.150-4%34855209.225+11%34394532.345+13%29908288.996+30%
Usd Book Value Change Per Share--0.3800.008+4581%0.198+92%0.162+135%0.141+170%
Usd Book Value Per Share--3.2323.367-4%2.906+11%2.861+13%2.488+30%
Usd Dividend Per Share----0%0.128-100%0.946-100%0.844-100%
Usd Enterprise Value--201604202.104220484223.476-9%272710904.381-26%259932509.761-22%259932509.761-22%
Usd Eps--0.4700.411+14%0.353+33%0.309+52%0.310+52%
Usd Free Cash Flow--15138773.7006941882.425+118%6661563.900+127%800992.485+1790%1263468.457+1098%
Usd Free Cash Flow Per Share--1.2630.579+118%0.555+127%0.066+1802%0.105+1106%
Usd Free Cash Flow To Equity Per Share---0.2300.026-998%0.180-228%-0.199-14%-0.148-36%
Usd Market Cap326989540.280+21%259084971.004277314674.376-7%337152960.356-23%279557755.360-7%243093700.313+7%
Usd Price Per Share27.271+21%21.60723.128-7%28.111-23%23.292-7%20.254+7%
Usd Profit--5635739.7004929567.775+14%3931014.975+43%3648651.095+54%3668276.926+54%
Usd Revenue--31686220.10029893650.000+6%25580835.425+24%22076250.745+44%21281861.770+49%
Usd Total Gains Per Share--0.3800.008+4581%0.326+16%1.108-66%0.984-61%
 EOD+4 -4MRQTTM+21 -17YOY+26 -145Y+21 -1910Y+23 -17

3.3 Fundamental Score

Let's check the fundamental score of PharmaSGP Holding SE based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1514.506
Price to Book Ratio (EOD)Between0-18.438
Net Profit Margin (MRQ)Greater than00.178
Operating Margin (MRQ)Greater than00.274
Quick Ratio (MRQ)Greater than11.804
Current Ratio (MRQ)Greater than12.265
Debt to Asset Ratio (MRQ)Less than10.715
Debt to Equity Ratio (MRQ)Less than12.505
Return on Equity (MRQ)Greater than0.150.145
Return on Assets (MRQ)Greater than0.050.041
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of PharmaSGP Holding SE based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.059
Ma 20Greater thanMa 5025.570
Ma 50Greater thanMa 10024.956
Ma 100Greater thanMa 20023.812
OpenGreater thanClose26.200
Total5/5 (100.0%)

4. In-depth Analysis

4.1 About PharmaSGP Holding SE

PharmaSGP Holding SE manufactures and sells over-the-counter drugs and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage creams for the treatment of various pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Revitensin, a drug for the treatment of hair loss; Dorisol for neuralgia (nerve pain), headaches, and migraines; Fulminan, a beauty drink; Lindaven, a pharmaceutical drops to treat their unpleasant problem; and SCLEROCALMAN, a drug for the treatment of clogged cerebral blood vessels. It also offers Prostacalman, a medication for cystitis and urination discomfort in a benign enlarged prostate; Revoten for women with weak connective tissue; Mindalin, a micronutrient drink for a healthy cardiovascular system; MELISTON, a prescription-free tablets to treat anxiety, restlessness, and mood swings; Deruba, a cream for skin redness; Lentisol that prevents the formation of new pigment spots; Neodolor, a headache tablet; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. The company sells its products through pharmacies and wholesalers. It also exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.

Fundamental data was last updated by Penke on 2025-01-23 15:24:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Pharmasgp earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Pharmasgp to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 17.8% means that €0.18 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of PharmaSGP Holding SE:

  • The MRQ is 17.8%. The company is making a huge profit. +2
  • The TTM is 16.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ17.8%TTM16.5%+1.2%
TTM16.5%YOY15.3%+1.2%
TTM16.5%5Y16.6%-0.1%
5Y16.6%10Y17.6%-0.9%
4.3.1.2. Return on Assets

Shows how efficient Pharmasgp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pharmasgp to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.1% Return on Assets means that Pharmasgp generated €0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of PharmaSGP Holding SE:

  • The MRQ is 4.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.1%TTM3.5%+0.6%
TTM3.5%YOY2.8%+0.7%
TTM3.5%5Y4.6%-1.1%
5Y4.6%10Y4.0%+0.6%
4.3.1.3. Return on Equity

Shows how efficient Pharmasgp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pharmasgp to the Drug Manufacturers - Specialty & Generic industry mean.
  • 14.5% Return on Equity means Pharmasgp generated €0.15 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of PharmaSGP Holding SE:

  • The MRQ is 14.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 12.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.5%TTM12.3%+2.2%
TTM12.3%YOY11.2%+1.1%
TTM12.3%5Y13.9%-1.6%
5Y13.9%10Y12.7%+1.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of PharmaSGP Holding SE.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Pharmasgp is operating .

  • Measures how much profit Pharmasgp makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pharmasgp to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 27.4% means the company generated €0.27  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of PharmaSGP Holding SE:

  • The MRQ is 27.4%. The company is operating very efficient. +2
  • The TTM is 25.5%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ27.4%TTM25.5%+1.9%
TTM25.5%YOY24.6%+0.9%
TTM25.5%5Y23.9%+1.6%
5Y23.9%10Y24.9%-1.0%
4.3.2.2. Operating Ratio

Measures how efficient Pharmasgp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.00 means that the operating costs are €1.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of PharmaSGP Holding SE:

  • The MRQ is 1.000. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.827. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ1.000TTM0.827+0.173
TTM0.827YOY0.771+0.056
TTM0.8275Y0.763+0.064
5Y0.76310Y0.753+0.010
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of PharmaSGP Holding SE.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Pharmasgp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.26 means the company has €2.26 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of PharmaSGP Holding SE:

  • The MRQ is 2.265. The company is able to pay all its short-term debts. +1
  • The TTM is 2.285. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.265TTM2.285-0.020
TTM2.285YOY2.293-0.008
TTM2.2855Y2.737-0.452
5Y2.73710Y2.380+0.357
4.4.3.2. Quick Ratio

Measures if Pharmasgp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pharmasgp to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.80 means the company can pay off €1.80 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of PharmaSGP Holding SE:

  • The MRQ is 1.804. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.840. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.804TTM1.840-0.036
TTM1.840YOY1.888-0.048
TTM1.8405Y2.402-0.562
5Y2.40210Y2.089+0.313
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of PharmaSGP Holding SE.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Pharmasgp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pharmasgp to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.71 means that Pharmasgp assets are financed with 71.5% credit (debt) and the remaining percentage (100% - 71.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of PharmaSGP Holding SE:

  • The MRQ is 0.715. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.713. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.715TTM0.713+0.002
TTM0.713YOY0.748-0.035
TTM0.7135Y0.637+0.076
5Y0.63710Y0.554+0.083
4.5.4.2. Debt to Equity Ratio

Measures if Pharmasgp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pharmasgp to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 250.5% means that company has €2.51 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of PharmaSGP Holding SE:

  • The MRQ is 2.505. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.519. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.505TTM2.519-0.014
TTM2.519YOY2.979-0.459
TTM2.5195Y2.508+0.011
5Y2.50810Y2.181+0.327
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Pharmasgp generates.

  • Above 15 is considered overpriced but always compare Pharmasgp to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 11.49 means the investor is paying €11.49 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of PharmaSGP Holding SE:

  • The EOD is 14.506. Based on the earnings, the company is underpriced. +1
  • The MRQ is 11.493. Based on the earnings, the company is underpriced. +1
  • The TTM is 14.245. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD14.506MRQ11.493+3.013
MRQ11.493TTM14.245-2.753
TTM14.245YOY20.287-6.041
TTM14.2455Y54.432-40.187
5Y54.43210Y47.333+7.100
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of PharmaSGP Holding SE:

  • The EOD is 5.400. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 4.278. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -9.197. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD5.400MRQ4.278+1.122
MRQ4.278TTM-9.197+13.475
TTM-9.197YOY13.611-22.808
TTM-9.1975Y13.400-22.597
5Y13.40010Y11.652+1.748
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Pharmasgp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 6.69 means the investor is paying €6.69 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of PharmaSGP Holding SE:

  • The EOD is 8.438. Based on the equity, the company is overpriced. -1
  • The MRQ is 6.685. Based on the equity, the company is overpriced. -1
  • The TTM is 6.970. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD8.438MRQ6.685+1.752
MRQ6.685TTM6.970-0.285
TTM6.970YOY9.735-2.764
TTM6.9705Y13.649-6.679
5Y13.64910Y11.869+1.780
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets129,516
Total Liabilities92,568
Total Stockholder Equity36,948
 As reported
Total Liabilities 92,568
Total Stockholder Equity+ 36,948
Total Assets = 129,516

Assets

Total Assets129,516
Total Current Assets67,452
Long-term Assets62,064
Total Current Assets
Cash And Cash Equivalents 37,767
Net Receivables 15,971
Inventory 10,959
Total Current Assets  (as reported)67,452
Total Current Assets  (calculated)64,697
+/- 2,755
Long-term Assets
Property Plant Equipment 920
Long-term Assets Other 669
Long-term Assets  (as reported)62,064
Long-term Assets  (calculated)1,589
+/- 60,475

Liabilities & Shareholders' Equity

Total Current Liabilities29,782
Long-term Liabilities62,786
Total Stockholder Equity36,948
Total Current Liabilities
Short-term Debt 483
Accounts payable 13,047
Other Current Liabilities 13,163
Total Current Liabilities  (as reported)29,782
Total Current Liabilities  (calculated)26,693
+/- 3,089
Long-term Liabilities
Capital Lease Obligations 608
Long-term Liabilities  (as reported)62,786
Long-term Liabilities  (calculated)608
+/- 62,178
Total Stockholder Equity
Common Stock12,000
Retained Earnings -13,104
Other Stockholders Equity 38,052
Total Stockholder Equity (as reported)36,948
Total Stockholder Equity (calculated)36,948
+/-0
Other
Capital Stock12,000
Cash and Short Term Investments 37,767
Common Stock Shares Outstanding 11,991
Liabilities and Stockholders Equity 129,516
Net Debt -37,159
Net Invested Capital 36,948
Net Working Capital 37,670
Property Plant and Equipment Gross 920
Short Long Term Debt Total 608



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
0
0
0
103,741
109,090
24,126
23,567
24,944
25,814
28,031
129,113
115,259
119,345
121,005
125,503
129,109
133,559
132,794
131,494
131,299
140,929
134,154
129,516
129,516134,154140,929131,299131,494132,794133,559129,109125,503121,005119,345115,259129,11328,03125,81424,94423,56724,126109,090103,741000
   > Total Current Assets 
77,008
0
0
102,093
107,651
21,493
21,161
22,365
22,975
23,976
44,186
32,530
38,764
41,015
45,807
51,509
58,532
59,755
60,544
62,817
73,933
69,064
67,452
67,45269,06473,93362,81760,54459,75558,53251,50945,80741,01538,76432,53044,18623,97622,97522,36521,16121,493107,651102,0930077,008
       Cash And Cash Equivalents 
-77,008
0
0
88,476
93,337
5,260
6,604
8,001
10,031
12,499
14,175
20,824
22,456
25,957
28,367
32,642
37,310
36,572
36,596
40,766
46,270
40,397
37,767
37,76740,39746,27040,76636,59636,57237,31032,64228,36725,95722,45620,82414,17512,49910,0318,0016,6045,26093,33788,47600-77,008
       Short-term Investments 
154,016
0
0
0
0
0
0
0
0
0
0
0
0
0
1,006
1,240
1,028
1,442
1,454
0
0
0
0
00001,4541,4421,0281,2401,0060000000000000154,016
       Net Receivables 
0
0
0
9,188
11,819
13,214
10,750
9,410
6,630
6,565
11,666
6,486
8,926
8,177
9,497
7,763
8,902
9,325
10,104
8,922
14,306
15,996
15,971
15,97115,99614,3068,92210,1049,3258,9027,7639,4978,1778,9266,48611,6666,5656,6309,41010,75013,21411,8199,188000
       Other Current Assets 
0
0
0
2,333
188
481
313
1,918
3,011
1,613
13,790
1,035
1,514
893
1,624
2,862
2,957
2,898
2,750
3,012
3,274
3,049
18,726
18,7263,0493,2743,0122,7502,8982,9572,8621,6248931,5141,03513,7901,6133,0111,9183134811882,333000
   > Long-term Assets 
-77,008
0
0
1,648
1,439
2,634
2,405
2,579
2,839
4,055
84,927
82,729
80,581
79,990
79,696
77,600
75,027
73,039
70,950
68,482
66,996
65,090
62,064
62,06465,09066,99668,48270,95073,03975,02777,60079,69679,99080,58182,72984,9274,0552,8392,5792,4052,6341,4391,64800-77,008
       Property Plant Equipment 
0
0
0
254
3
794
758
753
797
695
634
541
434
1,770
1,661
1,573
1,466
1,337
1,309
1,176
1,087
1,040
920
9201,0401,0871,1761,3091,3371,4661,5731,6611,7704345416346957977537587943254000
       Intangible Assets 
0
0
0
1,394
1,436
1,515
1,587
1,766
1,953
3,271
84,293
82,188
80,147
78,074
76,042
73,943
71,887
69,838
67,872
66,056
64,294
62,268
0
062,26864,29466,05667,87269,83871,88773,94376,04278,07480,14782,18884,2933,2711,9531,7661,5871,5151,4361,394000
       Long-term Assets Other 
-77,008
0
0
0
0
1
60
60
178
178
0
0
0
146
1,006
1,240
1,028
1,442
1,454
1,250
64,294
1,782
669
6691,78264,2941,2501,4541,4421,0281,2401,006146000178178606010000-77,008
> Total Liabilities 
0
0
0
8,161
9,911
16,154
12,173
13,437
13,129
12,323
109,309
93,062
95,467
99,543
97,943
98,012
100,184
100,921
94,918
91,545
96,264
101,547
92,568
92,568101,54796,26491,54594,918100,921100,18498,01297,94399,54395,46793,062109,30912,32313,12913,43712,17316,1549,9118,161000
   > Total Current Liabilities 
0
0
0
7,942
9,911
15,671
11,684
13,035
12,716
11,991
108,986
92,728
95,117
98,166
18,847
22,742
25,039
29,709
23,665
24,594
29,179
38,646
29,782
29,78238,64629,17924,59423,66529,70925,03922,74218,84798,16695,11792,728108,98611,99112,71613,03511,68415,6719,9117,942000
       Short-term Debt 
0
0
0
254
3
735
719
-2,529
321
322
276
85,193
113
419
390
8,063
404
404
444
8,155
8,213
481
483
4834818,2138,1554444044048,06339041911385,193276322321-2,5297197353254000
       Short Long Term Debt 
0
0
0
0
0
503
490
0
0
0
0
85,000
0
0
0
7,659
0
0
0
0
0
0
0
00000007,65900085,000000049050300000
       Accounts payable 
0
0
0
811
3,793
10,198
7,708
9,790
9,325
8,840
9,019
4,519
7,194
9,446
7,719
8,786
12,181
10,894
10,024
9,920
14,222
7,194
13,047
13,0477,19414,2229,92010,02410,89412,1818,7867,7199,4467,1944,5199,0198,8409,3259,7907,70810,1983,793811000
       Other Current Liabilities 
0
0
0
1,547
6,115
-3,032
-3,920
164
733
620
727
2,390
602
1,147
1,191
5,528
1,147
6,590
237
5,103
5,060
28,807
13,163
13,16328,8075,0605,1032376,5901,1475,5281,1911,1476022,390727620733164-3,920-3,0326,1151,547000
   > Long-term Liabilities 
0
0
0
219
0
483
489
402
413
332
323
334
350
1,377
79,096
75,270
75,145
71,212
71,253
66,951
67,085
62,901
62,786
62,78662,90167,08566,95171,25371,21275,14575,27079,0961,3773503343233324134024894830219000
       Other Liabilities 
0
0
0
0
241
234
298
257
295
294
320
333
350
371
78,187
74,454
0
1,352
0
0
0
0
0
000001,352074,45478,1873713503333202942952572982342410000
> Total Stockholder Equity
84,374
0
0
95,580
98,938
7,972
11,394
11,507
12,685
15,708
19,804
22,197
23,878
21,462
27,560
31,097
33,375
31,873
36,576
39,754
44,665
32,607
36,948
36,94832,60744,66539,75436,57631,87333,37531,09727,56021,46223,87822,19719,80415,70812,68511,50711,3947,97298,93895,5800084,374
   Common Stock
0
0
0
95,580
98,938
12,000
12,000
12,000
12,000
12,000
12,000
12,000
12,000
12,000
12,000
12,000
12,000
12,000
12,000
12,000
12,000
12,000
12,000
12,00012,00012,00012,00012,00012,00012,00012,00012,00012,00012,00012,00012,00012,00012,00012,00012,00012,00098,93895,580000
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 
84,374
0
0
0
0
-11,134
-11,134
38,120
38,120
38,120
38,120
38,120
38,120
38,120
2,152
2,346
1,779
2,135
2,052
481
833
964
0
09648334812,0522,1351,7792,3462,15238,12038,12038,12038,12038,12038,12038,120-11,134-11,134000084,374
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
-22,268
-22,268
38,120
38,120
38,120
38,120
38,120
38,120
38,120
38,120
38,120
38,120
-283
38,120
-286
38,120
38,120
38,052
38,05238,12038,120-28638,120-28338,12038,12038,12038,12038,12038,12038,12038,12038,12038,120-22,268-22,26800000



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue101,099
Cost of Revenue-9,462
Gross Profit91,63791,637
 
Operating Income (+$)
Gross Profit91,637
Operating Expense-50,723
Operating Income24,63840,914
 
Operating Expense (+$)
Research Development0
Selling General Administrative7,342
Selling And Marketing Expenses43,381
Operating Expense50,72350,723
 
Net Interest Income (+$)
Interest Income1,436
Interest Expense-4,410
Other Finance Cost-203
Net Interest Income-2,771
 
Pretax Income (+$)
Operating Income24,638
Net Interest Income-2,771
Other Non-Operating Income Expenses0
Income Before Tax (EBT)21,89327,383
EBIT - interestExpense = 22,087
21,893
20,807
Interest Expense4,410
Earnings Before Interest and Taxes (EBIT)26,49726,303
Earnings Before Interest and Taxes (EBITDA)35,868
 
After tax Income (+$)
Income Before Tax21,893
Tax Provision-4,928
Net Income From Continuing Ops14,99116,965
Net Income16,397
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses76,307
Total Other Income/Expenses Net-2,7452,771
 

Technical Analysis of Pharmasgp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pharmasgp. The general trend of Pharmasgp is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pharmasgp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of PharmaSGP Holding SE.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 27.00 < 27.00 < 27.00.

The bearish price targets are: 23.40 > 23.40 > 23.40.

Tweet this
PharmaSGP Holding SE Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of PharmaSGP Holding SE. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

PharmaSGP Holding SE Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of PharmaSGP Holding SE. The current macd is 0.28027593.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pharmasgp price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Pharmasgp. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Pharmasgp price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
PharmaSGP Holding SE Daily Moving Average Convergence/Divergence (MACD) ChartPharmaSGP Holding SE Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of PharmaSGP Holding SE. The current adx is 17.93.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Pharmasgp shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
PharmaSGP Holding SE Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of PharmaSGP Holding SE. The current sar is 24.29.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
PharmaSGP Holding SE Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of PharmaSGP Holding SE. The current rsi is 56.06. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
PharmaSGP Holding SE Daily Relative Strength Index (RSI) ChartPharmaSGP Holding SE Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of PharmaSGP Holding SE. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pharmasgp price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
PharmaSGP Holding SE Daily Stochastic Oscillator ChartPharmaSGP Holding SE Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of PharmaSGP Holding SE. The current cci is 48.44.

PharmaSGP Holding SE Daily Commodity Channel Index (CCI) ChartPharmaSGP Holding SE Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of PharmaSGP Holding SE. The current cmo is 15.22.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
PharmaSGP Holding SE Daily Chande Momentum Oscillator (CMO) ChartPharmaSGP Holding SE Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of PharmaSGP Holding SE. The current willr is -45.45454545.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Pharmasgp is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
PharmaSGP Holding SE Daily Williams %R ChartPharmaSGP Holding SE Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of PharmaSGP Holding SE.

PharmaSGP Holding SE Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of PharmaSGP Holding SE. The current atr is 0.56427079.

PharmaSGP Holding SE Daily Average True Range (ATR) ChartPharmaSGP Holding SE Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of PharmaSGP Holding SE. The current obv is 44,589.

PharmaSGP Holding SE Daily On-Balance Volume (OBV) ChartPharmaSGP Holding SE Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of PharmaSGP Holding SE. The current mfi is 66.57.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
PharmaSGP Holding SE Daily Money Flow Index (MFI) ChartPharmaSGP Holding SE Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for PharmaSGP Holding SE.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-10-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-01-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-24STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

PharmaSGP Holding SE Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of PharmaSGP Holding SE based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.059
Ma 20Greater thanMa 5025.570
Ma 50Greater thanMa 10024.956
Ma 100Greater thanMa 20023.812
OpenGreater thanClose26.200
Total5/5 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Pharmasgp with someone you think should read this too:
  • Are you bullish or bearish on Pharmasgp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pharmasgp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about PharmaSGP Holding SE

I send you an email if I find something interesting about PharmaSGP Holding SE.


Comments

How you think about this?

Leave a comment

Stay informed about PharmaSGP Holding SE.

Receive notifications about PharmaSGP Holding SE in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.